Literature DB >> 5937523

Histological grading in carcinoma of the breast.

B Wolff.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5937523      PMCID： PMC2008059          DOI： 10.1038/bjc.1966.5

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  1 in total

1.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640
  1 in total
  9 in total

1.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Influence of diet on breast cancer size and morphology in rats treated with DMBA.

Authors:  U Torsten; D Senger; H K Weitzel
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

3.  Breast cancer in women under 30 years of age.

Authors:  F Tabbane; A el May; M Hachiche; J Bahi; M Jaziri; M Cammoun; N Mourali
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.

Authors:  H J Bloom; W W Richardson; J R Field
Journal:  Br Med J       Date:  1970-07-25

5.  The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.

Authors:  C W Elston; G A Gresham; G S Rao; T Zebro; J L Haybittle; J Houghton; G Kearney
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

6.  Fibrosis as in indication of time in infiltrating breast cancer and its importance in prognosis.

Authors:  O T Anastassiades; D M Pryce
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

7.  Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.

Authors:  P V Maynard; C J Davies; R W Blamey; C W Elston; J Johnson; K Griffiths
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

8.  Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution.

Authors:  Silvia Antolín; Benigno Acea; Luis Albaina; Ángel Concha; Paz Santiago; Tomás García-Caballero; Joaquín J Mosquera; José Ramón Varela; Rafaela Soler; Lourdes Calvo
Journal:  Breast Cancer (Dove Med Press)       Date:  2018-12-27

Review 9.  Grading of invasive breast carcinoma: the way forward.

Authors:  C van Dooijeweert; P J van Diest; I O Ellis
Journal:  Virchows Arch       Date:  2021-07-01       Impact factor: 4.535
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.